We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
2022 ERS/ESC PH Guidelines on Diagnosis
Jean M. Elwing, MD
Essential Aspects of the New ERS/ESC Guidelines on PH Treatment: An Overview
Richard N. Channick, MD
Hot Topics from the New ERS/ESC PH Guidelines: Focus on Treatment
Ioana Preston, MD
Rajan Saggar, MD
Implications of Aggressive Therapy in ‘PAH Without Comorbidities’
Essential Aspects of the New ERS/ESC Treatment Guidelines: Patients Without Comorbidities
How Should Cardiopulmonary Comorbidities Influence PH Treatment Strategy?
Richard Krasuski, MD
Risk Assessment in PAH
Case: Using the 2022 ESC/ERS Treatment Algorithm in Older Male Patient with Cardiopulmonary Comorbidities
Hot Topics from the New ERS/ESC Guidelines: Definitions and Risk Assessment
Essential Aspects of the New ERS/ESC Treatment Guidelines: Patients With Comorbidities
Treatment Approaches to ILD-PH
Oksana A. Shlobin, MD
Sudarshan Rajagopal, MD, PhD
Implementing Aggressive Treatment to Improve Risk Profiles for Pulmonary Hypertension Patients
2022 ERS/ESC PAH Guidelines on Treatment
Implications of Aggressive in ‘PAH with comorbidities’ Therapy: What Does That Mean?
NSCLC Therapy Management and Biomarker Testing
Mark Socinski, MD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education